Department of Animal Biotechnology, LLR University of Veterinary and Animal Sciences, Hisar, Haryana, 125004, India.
Department of Animal Biotechnology, LLR University of Veterinary and Animal Sciences, Hisar, Haryana, 125004, India.
Biomed Pharmacother. 2018 Jan;97:1521-1537. doi: 10.1016/j.biopha.2017.11.026. Epub 2017 Nov 21.
In recent years nanotechnology has revolutionized the healthcare strategies and envisioned to have a tremendous impact to offer better health facilities. In this context, medical nanotechnology involves design, fabrication, regulation, and application of therapeutic drugs and devices having a size in nano-range (1-100 nm). Owing to the revolutionary implications in drug delivery and gene therapy, nanotherapeutics has gained increasing research interest in the current medical sector of the modern world. The areas which anticipate benefits from nano-based drug delivery systems are cancer, diabetes, infectious diseases, neurodegenerative diseases, blood disorders and orthopedic problems. The development of nanotherapeutics with multi-functionalities has considerable potential to fill the lacunae existing in the present therapeutic domain. Nanomedicines in the field of cancer management have enhanced permeability and retention of drugs thereby effectively targeting the affected tissues. Polymeric conjugates of asparaginase, polymeric micelles of paclitaxel have been recmended for various types of cancer treatment .The advancement of nano therapeutics and diagnostics can provide the improved effectiveness of the drug with less or no toxicity concerns. Similarly, diagnostic imaging is having potential future applications with newer imaging elements at nano level. The newly emerging field of nanorobotics can provide new directions in the field of healthcare. In this article, an attempt has been made to highlight the novel nanotherapeutic potentialities of polymeric nanoparticles, nanoemulsion, solid lipid nanoparticle, nanostructured lipid carriers, dendrimers, nanocapsules and nanosponges based approaches. The useful applications of these nano-medicines in the field of cancer, nutrition, and health have been discussed in details. Regulatory and safety concerns along with the commercial status of nanosystems have also been presented. In summary, a successful translation of emerging nanotherapeutics into commercial products may lead to an expansion of biomedical science. Towards the end of the review, future perspectives of this important field have been introduced briefly.
近年来,纳米技术彻底改变了医疗保健策略,并有望产生巨大影响,提供更好的医疗设施。在这种情况下,医学纳米技术涉及治疗药物和设备的设计、制造、调节和应用,其尺寸在纳米范围内(1-100nm)。由于在药物输送和基因治疗方面的革命性影响,纳米治疗在当今世界现代医学领域引起了越来越多的研究兴趣。预计从基于纳米的药物输送系统中受益的领域是癌症、糖尿病、传染病、神经退行性疾病、血液疾病和骨科问题。具有多功能性的纳米治疗的发展具有相当大的潜力来填补现有治疗领域的空白。癌症管理领域的纳米药物提高了药物的通透性和保留率,从而有效地靶向受影响的组织。已推荐天冬酰胺酶的聚合物缀合物、紫杉醇的聚合物胶束用于各种类型的癌症治疗。纳米治疗学和诊断学的进步可以提供提高药物的有效性,减少或没有毒性问题。同样,诊断成像具有潜在的未来应用,在纳米级具有更新的成像元素。新兴的纳米机器人领域可以为医疗保健领域提供新的方向。本文试图强调聚合物纳米粒子、纳米乳液、固体脂质纳米粒子、纳米结构脂质载体、树枝状大分子、纳米胶囊和纳米海绵的新型纳米治疗潜力。详细讨论了这些纳米药物在癌症、营养和健康领域的应用。还介绍了纳米系统的监管和安全问题以及商业状况。总之,将新兴的纳米治疗成功转化为商业产品可能会推动生物医学科学的发展。在综述的结尾,简要介绍了这个重要领域的未来展望。